Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 218

The House gets bigger with $44m second fund

UC Berkeley-focused House Fund II has raised $44m from investors including endowments for the university and the wider University of California ecosystem.

Nov 20, 2019

PsiQuantum swings $230m

University of Bristol-founded PsiQuantum has reportedly scooped funding from backers including an Andy Rubin fund as it looks to develop silicon-powered quantum computers.

Nov 19, 2019

StimAire implants UAVC funding

UAVenture Capital Fund II has backed University of Arizona spinout StimAire, which is working on neuromodulation-based treatments for conditions including obstructive sleep apnoea.

Nov 19, 2019

CL Educate clears university startup funding

The education services provider is set to invest $4.2m in university-based startups in support of open innovation platform Wain Connect.

Nov 19, 2019

Siren attracts $10m for series A round

Atlantic Bridge led a round for NUI Galway-founded organisational data investigation spinout Siren, having backed the company's seed round through its University Bridge Fund.

Nov 18, 2019

Daily deal net: November 15, 2019

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Nov 15, 2019

AMP amplifies $16m

UC-backed Congruent Ventures has returned to take part in a series A round for waste recycling robot company AMP Robotics.

Nov 15, 2019

Daily deal net: November 14, 2019

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Nov 14, 2019

Sera Prognostics diagnoses $36m series D

Based on research from Brigham Young University and University of Utah, Sera has added $36m to its funding vault to drive commercialisation of its blood testing system PreTRM.

Nov 14, 2019

PMV pinpoints $62m investment

OUP returned for PMV's series C round which the company will use to cement its portfolio of small molecule treatments targeting cancerous p53 mutations.

Nov 14, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here